当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 1天前 34 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-06-12 16:59:48 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

其他信息:

互助时间线

楼主确认了jodie0105应助的文件是正确的, 求助状态变成已完结

jodie0105上传了文件(zip 2.56 MB), 求助状态变成待确认

Colesevelam hydrochloride: synthesis and testing of a novel polymer gel pharmaceutical 6小时前

Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays 7小时前

Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy 8小时前

Quantitative Pharmacology Methods for Bispecific T Cell Engagers 8小时前

TRPA1 siRNA-Loaded Nanoformulation Ameliorates Chemotherapy-Induced Peripheral Neuropathy 9小时前

Targeting QPCTL: An Emerging Therapeutic Opportunity 10小时前

40 million deaths by 2050: toll of drug-resistant infections to rise by 70% 10小时前

A Deep-Learning-Aided Drug Screening Based on Visualization of a Hidden Layer as Chemical Space 11小时前

Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid- and steroid-based interventions 11小时前

分光光度法测定发芽和未发芽的蚕豆（Vicia faba L.）和鹰嘴豆（Cicer aritinum L.）中的 L-多巴 14小时前